NCT06500780

Brief Summary

This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm trial will randomize 304 patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system (Eskenazi). After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA and offered a 20-minute coaching session to walk them through it.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
13mo left

Started Aug 2024

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Aug 2024May 2027

First Submitted

Initial submission to the registry

July 8, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

August 13, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

2.8 years

First QC Date

July 8, 2024

Last Update Submit

November 20, 2025

Conditions

Keywords

chronic paindepressionhealth equityshared decision makingdecision aiddepressive symptoms

Outcome Measures

Primary Outcomes (4)

  • Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 3 months

    The pain interference score averages seven ratings, 0 (does not interfere) to 10 (completely interferes).

    3 months

  • Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 6 months

    The pain interference score averages seven ratings, 0 (does not interfere) to 10 (completely interferes).

    6 months

  • Change from Baseline Patient Health Questionnaire (PHQ)-8 at 3 months

    The Patient Health Questionnaire (PHQ)-8 is a widely-used, validated 8-item measure of depression severity that uses a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).

    3 months

  • Change from Baseline Patient Health Questionnaire (PHQ)-8 at 6 months

    The Patient Health Questionnaire (PHQ)-8 is a widely-used, validated 8-item measure of depression severity that uses a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).

    6 months

Secondary Outcomes (10)

  • Change from Baseline Generalized Anxiety Disorder (GAD)-7 at 3 months

    3 months

  • Change from Baseline Generalized Anxiety Disorder (GAD)-7 at 6 months

    6 months

  • Change from Baseline Pain Catastrophizing Scale at 3 months

    3 months

  • Change from Baseline Pain Catastrophizing Scale at 6 months

    6 months

  • Change from Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 3 months

    3 months

  • +5 more secondary outcomes

Other Outcomes (2)

  • Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 3 months

    3 months

  • Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 6 months

    6 months

Study Arms (2)

Coaching and Decision Aid

EXPERIMENTAL

Intervention group (Individual coaching sessions and Decision Aid)

Behavioral: Coaching and Decision Aid

Control

NO INTERVENTION

Wait-list control group

Interventions

Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents

Coaching and Decision Aid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible patients must
  • have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, shoulder) for ≥3 months,
  • have at least moderate pain intensity and interference with function, defined by a score ≥4 (possible range: 0-10) on the Pain, Enjoyment of Life and General Activity scale (PEG), a 3-item measure of pain intensity, interference with enjoyment of life, and interference with general activity,
  • have at least mild depression, defined as PHQ-8 score ≥5,
  • identify as Black or African American,
  • have consistent access to a telephone,
  • indicate openness to new pain treatments, and
  • have a scheduled appointment with their PCP in the next approximate 2-4 months or be willing to schedule one

You may not qualify if:

  • Patients are excluded:
  • if previously participated in Dr. Matthias' past pilot study (IRB #12885), the pilot RCT for this project (IRB #16571), or are participating as a Patient Engagement Panel member for this project (Aim 1.1),
  • if the eligibility screener or medical records indicate severe medical conditions likely precluding participation (e.g. stroke in the last 6 months, hospitalized with congestive heart failure or a heart attack in the last 6 months, cancer other than skin cancer and receiving active treatment), or
  • if the eligibility screener or medical records reveal (1) active suicidal ideation, or (2) severe hearing/speech or cognitive impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskenazi Health Primary Care

Indianapolis, Indiana, 46254, United States

RECRUITING

MeSH Terms

Conditions

Chronic PainMusculoskeletal PainDepression

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Adam T Hirsh, PhD

    Indiana University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Research Specialist

CONTACT

Jennifer Garabrant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Baseline assessments are conducted prior to randomization (Baseline assessor will not know the randomization assignment).
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 15, 2024

Study Start

August 13, 2024

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2027

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

NIH intends to maximize the impact of HEAL Initiative-supported projects through broad and rapid data sharing. All HEAL Initiative award recipients, regardless of the amount of direct costs requested for any one year, are required to comply with the HEAL Public Access and Data Sharing Policy, which also aligns with the NIH Policy for Data Management and Sharing (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html). HEAL award recipients must following all requirements and timelines developed through the HEAL Initiative Data Ecosystem, as described in HEAL's compliance guidance (https://heal.nih.gov/data/complying-heal-data-sharing-policy).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
At the time of publication of the primary manuscript
Access Criteria
Implementation of the plan will follow the HEAL Public Access and Data Sharing Policy.
More information

Locations